1. Home
  2. FINV vs NNNN Comparison

FINV vs NNNN Comparison

Compare FINV & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$5.17

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$27.70

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FINV
NNNN
Founded
2007
2021
Country
China
Germany
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
FINV
NNNN
Price
$5.17
$27.70
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.55
N/A
AVG Volume (30 Days)
1.9M
26.9K
Earning Date
11-19-2025
04-28-2026
Dividend Yield
5.44%
N/A
EPS Growth
27.76
N/A
EPS
1.50
0.06
Revenue
$1,969,555,571.00
$8,185,146.00
Revenue This Year
$5.54
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.51
$534.57
Revenue Growth
8.81
21.95
52 Week Low
$4.70
$5.18
52 Week High
$11.08
$55.65

Technical Indicators

Market Signals
Indicator
FINV
NNNN
Relative Strength Index (RSI) 42.34 48.35
Support Level $5.12 $26.89
Resistance Level $5.40 $44.73
Average True Range (ATR) 0.21 5.78
MACD 0.07 -0.21
Stochastic Oscillator 42.31 29.62

Price Performance

Historical Comparison
FINV
NNNN

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: